Retatrutide 20mg: The Ultimate Triple-Agonist Research Peptide
Unlock unprecedented analytical insights with Retatrutide 20mg, the single most anticipated advancement in peptide research science. Designed specifically for advanced metabolic, scientific, and cellular pathway studies, Retatrutide represents a massive leap forward from early single- and dual-acting agonists.
If your research institution demands precision, consistent potency, and verifiable molecular purity, our high-grade Retatrutide 20mg lyophilized powder provides the exact scientific standard required for high-impact experimental trials.
Why Retatrutide 20mg is Transforming Metabolic Research
Retatrutide (LY3437943) is an innovative synthetic peptide engineered to target three distinct metabolic receptor pathways simultaneously. While legacy single-agonist peptides target only GLP-1, and second-generation dual-agonists pair GLP-1 with GIP, Retatrutide introduces a powerful third target: the Glucagon (GCG) receptor.
By activating GLP-1, GIP, and Glucagon receptors concurrently, this revolutionary “triple-agonist” compound allows investigators to explore synergistic mechanisms in metabolic rate regulation, energy expenditure, lipid homeostasis, and glucose control within standardized research models.
Key Characteristics of Retatrutide 20mg:
-
Triple Receptor Binding: Simultaneous activation of GLP-1, GIP, and Glucagon pathways.
-
Optimal Research Concentration: 20mg dosage quantity ideal for extended, multi-phase trial sequences.
-
Lyophilized Form: Freeze-dried under vacuum conditions for extended shelf life and maximum structural integrity.
-
Ultra-High Purity: Exceeds 99% purity as verified by independent HPLC and Mass Spectrometry analysis.
Unmatched Purity for Superior Experimental Accuracy
Inconsistent laboratory reagents lead to frustrating analytical variances, compromised trial data, and wasted budget. We eliminate those uncertainties by manufacturing Retatrutide 20mg under stringent quality control protocols. Every batch undergoes rigorous batch testing to guarantee chemical stability, sequence fidelity, and freedom from residual contaminants or endotoxins.
| Product Specification | Attribute Detail |
| Chemical Name | Retatrutide (LY3437943) |
| CAS Number | 2381089-83-2 |
| Sequence | Modified synthetic peptide sequence |
| Molecular Formula | C221H342N46O68 |
| Net Quantity | 20mg per vial |
| Form | Lyophilized powder |
| Purity Grade | ≥99% (HPLC Verified) |
| Storage Requirements | Store at -20°C; protect from direct light exposure |
Targeted Applications in Biochemical Science
The multi-receptor mechanism of Retatrutide 20mg opens rich avenues for scientific inquiry across several critical biomedical disciplines:
1. Energy Expenditure & Thermogenesis Research
By engaging the glucagon receptor alongside incretin pathways, research models exhibit distinct shifts in basal metabolic activity. Investigators utilize Retatrutide to evaluate non-shivering thermogenesis and mitochondrial activity in brown adipose tissue.
2. Advanced Glycemic Control & Insulin Sensitivity
Dual GIP/GLP-1 activation stimulates glucose-dependent insulin secretion while modulating glucagon dynamics. Retatrutide provides a robust platform to measure pancreatic beta-cell response and peripheral insulin sensitivity under varied glycemic conditions.
3. Lipid Metabolism & Hepatic Health Studies
The glucagon signaling component plays a vital role in hepatic lipid clearance. Researchers frequently implement Retatrutide 20mg in liver tissue assays to examine fatty acid oxidation, lipid accumulation, and hepatic clearance dynamics.
Handling and Reconstitution Guidelines
To maintain the structural stability of the 20mg Retatrutide peptide chain, follow standard laboratory safety and reconstitution protocols:
-
Allow the vial to equalize to room temperature before reconstitution to avoid condensation buildup.
-
Reconstitute using sterile Bacteriostatic Water or Sterile Saline by gently directing the liquid down the inner glass wall.
-
Do not shake or agitate the vial vigorously; swirl gently until the lyophilized cake is fully dissolved.
-
Store reconstituted solutions at 2°C to 8°C and utilize within the designated stability window.
Disclaimer: This product is supplied strictly for In Vitro laboratory research and educational evaluation. It is not intended for human or animal diagnostic, therapeutic, or clinical application.




Reviews
There are no reviews yet.